NCT06774638View on ClinicalTrials.gov

Diagnostic and Prognostic Biomarkers in SARS-CoV-2 Infections

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

April 4, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

March 31, 2024

Conditions
IBD - Inflammatory Bowel DiseaseCOVID - 19
Trial Locations (1)

40138

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

NCT06774638 - Diagnostic and Prognostic Biomarkers in SARS-CoV-2 Infections | Biotech Hunter | Biotech Hunter